Mediplantex National Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Mediplantex National Pharmaceutical has a total shareholder equity of ₫331.0B and total debt of ₫80.5B, which brings its debt-to-equity ratio to 24.3%. Its total assets and total liabilities are ₫609.9B and ₫278.9B respectively. Mediplantex National Pharmaceutical's EBIT is ₫17.8B making its interest coverage ratio -7.2. It has cash and short-term investments of ₫51.2B.
Key information
24.3%
Debt to equity ratio
₫80.53b
Debt
| Interest coverage ratio | -7.2x |
| Cash | ₫51.15b |
| Equity | ₫331.03b |
| Total liabilities | ₫278.91b |
| Total assets | ₫609.93b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MED's short term assets (₫357.8B) exceed its short term liabilities (₫278.9B).
Long Term Liabilities: MED has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: MED's net debt to equity ratio (8.9%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if MED's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: MED's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: MED earns more interest than it pays, so coverage of interest payments is not a concern.